EurekAlert! -
25 Aug 2014 06:00
(National University of Singapore) A team of scientists led by research associate professor Motomi Osato and professor Yoshiaki Ito from the Cancer Science Institute of Singapore at the National University of Singapore found that a drug originally designed for killing a limited type of cancer cells with DNA repair defects could potentially be used to treat leukemia and other cancers.
Share this Article